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ABSTRACT 
This study aimed to determine the activity of polysaccharide krestin (PSK) from Coriolus versicolor extract to the dura-
tion of estrous cycle and estradiol levels. PSK was administrated for 24 days in female Mus musculus, strain Balb/C, 10 
weeks old, weight about 25-30 grams. Polysaccharide krestin given in sub-chronic dose. There were 4 groups, i.e K0 (0 
mg/kg BW), P1 (15 mg/kg BW), P2 (30 mg/kg BW), and P3 (60 mg/kg BW). Each treatment group contained 7 replica-
tions. Data were analyzed using One Way ANOVA and Duncan test at α = 5%. The duration of estrous cycle was de-
termined by vaginal smear methods. The estradiol levels were measured using ELISA kit. The results show that the 
administration of PSK decreased the duration of estrous cycle with an average of 4.4 days. Polysaccharide krestin dose 
of 15 and 60 mg/kg BW did not affect the estradiol levels. Decrease of estrous cycle duration was still in the range of 
normal estrous time between 4-6 days. PSK dose of 15 and 60 mg/kg BW can be used as a therapeutic dose.  
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The usage of mushroom as anti-viral and anti-cancer 
has been proven. More than 50 species have been tested 
on animals. Coriolus versicolor mushroom or yun zhi 
been known at the time of the Ming Dynasty of China. 
The mushroom is classified in sub-class Homobasidiomy-
cetes and family Polyporaceae (Ho et al., 2006). 
Polysaccharopeptide can be obtained from C. versi-
color, known as Coriolus versicolor polysaccharides 
(CVP) or polysaccharides krestin. The main component 
of PSK is β-glucan (Zhang et al., 2001). Polysaccharides 
krestin have many pharmacological activities, as an adju-
vant in the immune system (Noguchi et al., 1995), in-
creasing the number of leukocytes and macrophages 
(Wahyuningsih, 2006). 
With the facts and the description above, the benefits 
of PSK from the mushroom C. versicolor is not in doubt. 
Nevertheless, PSK component is not necessarily safe. 
Excessive use may cause a bad influence. According 
Murtini et al. (2010), all the substances that enter into 
body would potentially be toxic materials. The toxicity of 
the material depends on the dose consumed and the long 
period of usage. 
PSK is beneficial to increase the production of cyto-
kines, such as interleukin-1 (IL-1), IL-2, IL-4, IL-6, IL-7 
and IL-8 (Noguchi et al., 1995). Cytokines IL-1, IL-2, 
and IL-6 give a signal to the brain to activate the hypotha-
lamic-pituitary-adrenal (HPA) axis in response to an im-
mune stress. HPA axis actively stimulates the secretion of 
adrenocorticotropic hormone (ACTH). The ACTH stimu-
lates the secretion of glukortikoid. If the use of PSK in the 
long run, it will increase the secretion of gluco-corticoids 
and will suppress the HPG axis at a rate supra-pituitary. It 
will suppress gonadotropin-releasing hormone (GnRH) 
produced by the anterior pituitary. A decrease of GnRH 
will reduce production of the reproduction hormone, such 
as follicle stimulating hormone (FSH) and luteinezing 
hormone (LH). GnRH suppression can reduce the produc-
tion of FSH and LH. Decrease of FSH production will 
inhibit the ovarian follicles maturation, thus it also 
inhibits ovulation. If ovulation is inhibited, it will extend 
the duration of the estrous cycle. LH decline will also 
affect the production of the hormone estrogen or estradiol 
(Kirby et al., 2009).  
The estrous cycle is a period that is physiologically 
can receive a stud or a series of events related to the prep-
aration of the uterus for the reception and implantation of 
the ovum. The estrous cycle can be divided into four 
stages: proestrus, estrus, metestrus, and diestrus. This 
cycle coincides with the maturation of ovarian follicles 
stimulated by FSH. FSH production stimulated by GnRH 
(Freeman,1994; Sarkar et al., 1976). 
Estrogen is a female reproductive hormone in ani-
mals. This hormone is mainly secreted by the granulosa 
cells of ovarian follicles constituent. Estrogen takes role 
on GnRH regulation. On the basis of this study wanted to 
test the effect of extracts of PSK from C. versicolor 
against the estrous cycle length and estradiol levels in 
mice (Mus musculus). 
THE EFFECT OF POLYSACCHARIDES KRESTIN BIOACTIVITY FROM 
Coriolus versicolor TO ESTRADIOL LEVELS ON  
Mus musculus ESTROUS CYCLE 
INTRODUCTION 
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Animal materials 
This research used female mice (Mus musculus), 
Balb/C strain, aged 10 weeks, weight about 25-30 g. Mice 
were acclimatized for 7 days for adjustment to the envi-
ronment the animal cages. 
 
Polysaccharide krestin extraction 
Fruit body of C. versicolor can be foud grows on 
dead wood, or trees that were not productive during the 
rainy season. Fungal fruiting body was dried and made a 
coarse powder in a blender (Wahyuningsih et al., 2009). 
Coriolus versicolor mushroom extract production was 
done according to the method of Cui and Chisti (2003) 
and Wahyuningsih et al. (2009). This step would get dried 
mushroom extract. Mushroom extracts precipitated with 
90% ammonium sulphate. In this process would produce 
a rough polysaccharopeptide. Further, it was diluted with 
PBS solution. The solution was dialyzed for 24 hours. 
This process would produce a solution of PSK (Wahyun-
ingsih et al., 2009). 
 
PSK treatment in experimental animals  
PSK solution was given to female mice orally with 
repeated doses. Polysaccharides krestin was given for 5 
times the estrous cycle or 24 days. There are four groups 
for treatment, ie 1. The control group (K, 0 mg/kg BW), 
2. PSK group of 15 mg/kg BW (P1), 3. PSK group of 30 
mg/kg BW (P2), and 4. PSK group of 60 mg/kg BW (P3). 
 
Observation of animal estrous cycle length 
The estrous cycle length was observed by vaginal 
smear per hour 8-10 am for 5 times from the time of the 
estrous cycle or 24 days (Cooper et al., 1993). Results 
obtained are determined phase and counted how many 
times the period of one full cycle at each repetition. Fur-
thermore, the data were averaged. 
 
Isolation of blood serum 
Blood was collected from the heart. Blood put in a 
centrifuge and placed oblique. After that, it stored at 4°C 
overnight. Then centrifuged at 3000 rpm at temperature of 
4°C for 15 minutes and taken the serum. Serum was 
stored at -20ºC until the measured levels of estradiol. 
 
Estradiol level measurement 
Estradiol levels were measured using ELISA Kit 
(17-β-estradiol mice, Elabscience). Serum estradiol levels 
were measured with a microplate reader, a wavelength of 
450 nm. After knowing the value OD, then the standard 




Data were analyzed statistically. Prior to the statisti-
cal test, all the data was tested first distribution normality 
and homogeneity of its variants. Data of normal and ho-
mogeneous were tested by using one-way ANOVA. Dif-
ferences between treatments were analyzed by Duncan 
test. 
 
The mouse estrous cycle is 4-6 days. The infor-
mation below refers to determining the stage of the es-
trous cycle in the mouse by the appearance of the vagina. 
Result of observation estrous cycles including changes in 
the vaginal epithelium of each phase can be seen in Fig-
ures 1, 2, 3, and 4. 
Proestrus (Figure 1) was showed by the presence of 
nucleated epithelial cells that are round. However, 
sometimes these cornify rapidly, especially in mice. 
Estrus (Figure 2) was characterized by non-nucleated, 
cornified epithelial cells. Metestrus typically (Figure 3) 
had a low cell number, often with a lot of cell debris. 
Diestrus (Figure 4) contained mostly leukocytes. 
Figure 5 shows the length of the estrous cycle time. 
Vaginal epithelium looks determined phase and then the 
data results of the phase count how many times the period 
of a full cycle. The study of the estrous cycle length 
showed shorter cycles. Analysis of the estrous cycle 
length showed cycles were getting shorter. In the control 
group and the treatment P1 showed estrous cycle length 
of 4.8 days, whereas the treatment group P2 and P3 long-
cycle produces about 4.7 and 4.4 days. The statistical re-
sults showed that the treatment group was not significant-
ly different from P3 to P2 group, but significantly differ-
ent with group K0 and P1. The length of the estrous cycle 
in this research shortened in the treatment group P3, but it 
is still in the range of a normal cycle in mice.  According 
Caligioni and Franci (2002), the length of the estrous cy-
cle of a normal cycle in mice was between 4-5 days 
Figure 6 shows the concentration of serum estradiol. 
Results of a study of 17-β estradiol levels indicated that 
treatment group K0, P1, P2 and P3, respectively produced 
estradiol was 26094.92, 25162.89, 15609.56, and 
21609.51 pg/mL. Measurement of 17 β-estradiol levels in 
the control group did not differ significantly by treatment 
group P1, P2, and P3. This showed that there was no ef-




Research on the toxicity of polysaccharide peptide 
sub-chronic been done by Jian et al. (1999) in Cheng and 
Leung (2008) with a dose of (0, 1.5, 3, and 6 mg/kg BW) 
showed no toxic symptoms or no death in experimental 
animals. Sub-chronic effects of C. versicolor on organs, 
tissues, and cells had been widely studied by Cheng and 
Leung (2008). However, not much research related to the 
effects of C. versicolor specific toxicity to reproductive 
organs, particularly in the female reproductive organs. 
Polysaccharide krestin of the mushroom C. versicol-
or was used as immuno-potential, can increase the pro-
duction of cytokines, such as IL-1, IL-2, IL-4, IL-6, IL-7 
and IL-8 (Noguchi et al., 1995). Interleukin-6 (IL-6) has 
been known to have several functions, among others regu-
late differentiation, stimulation, and activation of immune 
cells and some inflammatory reaction (Arzt, 2001, Gau-
tron et al., 2003). Recent studies have also shown that IL-
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various levels of the HPA axis during the local inflamma-
tory process (Bethin et al., 2000; Gautron et al., 2003). 
Interleukin-6 is mainly stimulates the release of the hor-
mone prolactin (PRL), growth hormone (GH), ACTH, 
FSH and LH from the anterior pituitary (Renner et al., 
1996). In addition, IL-6 regulates the function of the ova-
ries, including regulation of the LH receptor (LHR) on 
granulosa cells (Tamura et al., 2000) and also has an im-
portant role in folliculogenesis and oocyte maturation 
(Loret et al., 1998). 
 
 
Figure 1.  Proestrus phase showed epithelial nuclei (arrow A) with a bit 
of leukocytes (arrow B). 
 
 
Figure 3.  Metestrus phase showed a mixture of three types of cells, i.e. 
the leukocytes (arrow A, at most), the nucleated epithelial cells (arrow 
B, a few), and the cornification of epithelial cells (arrow C, at least). 
 
 
Figure 5. Diagram of the average of estrous cycle length. Different 
letters indicate no significant difference. K0: control; P1: PSK dose of 




Figure 2.  Estrus Phase showed all epithelium undergoes cornification 
become core (arrows). 
 
 





Figure 6. Diagram of the average of 17-β estradiol level. The same letter 
showed no significant difference. K0: control; P1: PSK dose of 15 
mg/kg BW, P2: PSK dose of 30 mg/kg BW, P3: PSK dose of 60 mg/kg 
BW. 
Mechanism of IL-6 in regulating the function of the 
ovaries and LHR is through the increase of the hormone 
FSH. FSH induces the expression of LHR mRNA through 
the Janus kinase (JAK) (Tamura et al., 2000). PSK as 
immuno-potential may increase the secretion of IL-6. 
Increased IL-6 will result in an increase in FSH and LHR 
mRNA. Follicle stimulating hormone is a hormone essen-
tial to the development of ovarian follicles (Ulloa-Aguirre 
et al., 2003). If this hormone increases will accelerate the 
estrous cycle and folliculogenesis (Hamburg, 2005). In-
creased LHR may cause increased excretion of LH by the 
anterior pituitary (Ascoli and Puett, 2008). Luteinizing 
hormone that increases will result in the acceleration time 
of ovulation (Pratap & Sameer, 2011).  
Acceleration time of the phases of folliculogenesis 
and ovulation was what causes the shortening of the 
length of time the estrus cycle that occurs on the results of 
this study (Figure 5). It showed that the PSK in doses of 
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15-60 mg / kg body weight increased the levels of IL-6 
and FSH, which could shorten the estrus cycle. This is 
similar to study Tebar et al. (1998), the injection of FSH 
and LH increase levels of estradiol and shortening the 
length of time of the estrous cycle in mice. Although the 
estrous cycle on the research there was a decrease, but it 
was still within normal limits. 
In this study, estradiol levels did not change after the 
administration of PSK from C. versicolor extract. This 
was in line with research Jian et al. (1999) that the provi-
sion PSK sub-chronic dose did not affect blood and serum 
biochemistry.  
Based on data showed that at administration of PSK 
does not affected the lenght of estrous cycle. The research 
dose used PSK was a safe dose. It was a sub-chronic dos-
es or a dose below the LD50.  According to Chen and 
Leung (2008), the LD50 value of PSK was 26-300.36 
mg/kg for administered by intraperitoneous injection. The 
highest daily tolerant dose was over 18-20 g/kg for mice.  
Base on research, PSK dose of 15-60 mg/kg body 
weight did not affect the estrous cycle time, which was 
still within the normal range between 4-5 days. PSK dose 
of 15-60 mg/kg body weight did not affect the hormone 
levels of serum estradiol mice. It showed that PSK dose 
15-60 mg/kg body weight was the optimal dose that could 
be used without affecting the reproductive system. If this 
dose used for therapy in humans, it should be tested with 
advanced testing and doing research on another 
reproductive parameters with higher doses for long term 
or equal to this study. 
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